Sage Journals: Discover world-class research

Abstract

Chemically modified short interfering RNAs (siRNAs) unequivocally represent a groundbreaking class of drugs. The deliberate chemical modification of the natural structure has been pivotal to their resounding success. Specific modifications at certain positions bolster their potency, safety, stability, and specificity. In clinical research, 2′-O-methyl and 2′-fluoro are the most used modifications. The effects of a wide range of chemical changes in fully modified siRNAs have not been thoroughly evaluated for tolerability. In this study, we utilized two sequences in a fully modified siRNA to systematically assess the tolerability of single nucleotide backbone and sugar modifications, including deoxyribonucleic acid, 2′-O-(2-methoxyethyl), locked nucleic acid, unlocked nucleic acid, mismatches, butane diol substitution, and butane diol insertion. We synthesized 522 siRNA variants and evaluated their efficacy in vitro. Our findings demonstrate that individual tolerability is significantly influenced by the modification’s sequence, pattern, and position, with limited universal principles identifiable from this dataset. The efficacy results are probably driven by the thermodynamic balance defined by a combination of parameters. The framework presented here will serve as a reference dataset to facilitate the expansion of chemical diversity in therapeutic siRNAs.

Get full access to this article

View all access options for this article.

References

Khvorova

, Watts

. The chemical evolution of oligonucleotide therapies of clinical utility. Nat Biotechnol, 2017; 35:238–248; doi: 10.1038/nbt.3765

, Zhong

, Weng

, et al. Therapeutic siRNA: State of the art. Signal Transduct Target Ther, 2020; 5:101; doi: 10.1038/s41392-020-0207-x

Egli

, Manoharan

. Chemistry, structure and function of approved oligonucleotide therapeutics. Nucleic Acids Res, 2023; 51:2529–2573; doi: 10.1093/nar/gkad067

Watts

, Deleavey

, Damha

. Chemically modified siRNA: Tools and applications. Drug Discov Today, 2008; 13:842–855; doi: 10.1016/j.drudi5.2008.05.007

McKenzie

, El-Khoury

, Thorpe

, et al. Recent progress in non-native nucleic acid modifications. Chem Soc Rev, 2021; 50:5126–5164; doi: 10.1039/D0CS01430C

Deleavey

, Damha

. Designing chemically modified oligonucleotides for targeted gene silencing. Chem Biol, 2012; 19:937–954; doi: 10.1016/j.chembiol.2012.07.011

Wan

, Seth

. The medicinal chemistry of therapeutic oligonucleotides. J Med Chem, 2016; 59:9645–9667; doi: 10.1021/acs.jmedchem.6b00551

Haraszti

, Roux

, Coles

, et al. 5′-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo. Nucleic Acids Res, 2017; 45:7581–7592; doi: 10.1093/nar/gkx507

Parmar

, Brown

, Matsuda

, et al. Facile synthesis, geometry, and 2′-Substituent-dependent in vivo activity of 5′-(E)- and 5′-(Z)-Vinylphosphonate-Modified siRNA conjugates. J Med Chem, 2018; 61:734–744; doi: 10.1021/acs.jmedchem.7b01147

10.

Hassler

, Turanov

, Alterman

, et al. Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo. Nucleic Acids Res, 2018; 46:2185–2196; doi: 10.1093/nar/gky037

11.

Foster

, Brown

, Shaikh

, et al. Advanced siRNA designs further improve in vivo performance of GalNAc-siRNA conjugates. Mol Ther, 2018; 26:708–717; doi: 10.1016/j.ymthe.2017.12.021

12.

Chiu

, Rana

. RNAi in human cells: Basic structural and functional features of small interfering RNA. Mol Cell, 2002; 10:549–561; doi: 10.1016/s1097-2765(02)00652-4

13.

Bramsen

, Pakula

, Hansen

, et al. A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects. Nucleic Acids Res, 2010; 38:5761–5773; doi: 10.1093/nar/gkq341

14.

Bramsen

, Laursen

, Nielsen

, et al. A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity. Nucleic Acids Res, 2009; 37:2867–2881; doi: 10.1093/nar/gkp106

15.

Petersen

, Wengel

. LNA: A versatile tool for therapeutics and genomics. Trends Biotechnol, 2003; 21:74–81; doi: 10.1016/S0167-7799(02)00038-0

16.

K. Singh

, Koshkin

, Wengel

, et al. LNA (locked nucleic acids): Synthesis and high-affinity nucleic acid recognition. Chem Commun, 1998:455–456; doi: 10.1039/A708608C

17.

Song

, Wang

, Ma

, et al. Site-Specific modification using the 2’-Methoxyethyl group improves the specificity and activity of siRNAs. Mol Ther Nucleic Acids, 2017; 9:242–250; doi: 10.1016/j.omtn.2017.10.003

18.

Ui-Tei

, Naito

, Zenno

, et al. Functional dissection of siRNA sequence by systematic DNA substitution: Modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect. Nucleic Acids Res, 2008; 36:2136–2151; doi: 10.1093/nar/gkn042

19.

Campbell

, Wengel

. Locked vs. unlocked nucleic acids (LNAvs.UNA): contrasting structures work towards common therapeutic goals. Chem Soc Rev, 2011; 40:5680–5689; doi: 10.1039/C1CS15048K

20.

Laursen

, Pakula

, Gao

, et al. Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo. Mol Biosyst, 2010; 6:862–870; doi: 10.1039/B918869J

21.

Langkjaer

, Pasternak

, Wengel

. UNA (unlocked nucleic acid): A flexible RNA mimic that allows engineering of nucleic acid duplex stability. Bioorg Med Chem, 2009; 17:5420–5425; doi: 10.1016/j.bmc.2009.06.045

22.

Mangos

, Min

, Viazovkina

, et al. Efficient RNase H-directed cleavage of RNA promoted by antisense DNA or 2 ‘ F-ANA constructs containing acyclic nucleotide inserts. J Am Chem Soc, 2003; 125:654–661; doi: 10.1021/Ja025557o

23.

, Echeverria

, Sousa

, et al. Single-Stranded Phosphorothioated regions enhance cellular uptake of cholesterol-conjugated siRNA but not silencing efficacy. Mol Ther Nucleic Acids, 2020; 21:991–1005; doi: 10.1016/j.omtn.2020.07.029

24.

Schcuer-Larsen

, Rosenbohm

, J⊘Gensen

TJD

, et al. Introduction of a universal solid support for oligonucleotide synthesis. Nucleosides and Nucleotides, 1997; 16:67–80; doi: 10.1080/07328319708002522

25.

Elmén

, Thonberg

, Ljungberg

, et al. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res, 2005; 33:439–447; doi: 10.1093/nar/gki193

26.

Iribe

, Miyamoto

, Takahashi

, et al. Chemical modification of the siRNA seed region suppresses off-target effects by steric hindrance to base-pairing with targets. ACS Omega, 2017; 2:2055–2064; doi: 10.1021/acsomega.7b00291

27.

Mook

, Vreijling

, Wengel

, et al. In vivo efficacy and off-target effects of locked nucleic acid (LNA) and unlocked nucleic acid (UNA) modified siRNA and small internally segmented interfering RNA (sisiRNA) in mice bearing human tumor xenografts. Artif DNA PNA XNA, 2010; 1:36–44; doi: 10.4161/adna.1.1.12204

28.

Reynolds

, Leake

, Boese

, et al. Rational siRNA design for RNA interference. Nat Biotechnol, 2004; 22:326–330; doi: 10.1038/nbt936

29.

Teplova

, Minasov

, Tereshko

, et al. Crystal structure and improved antisense properties of 2′-O-(2-methoxyethyl)-RNA. Nat Struct Biol, 1999; 6:535–539; doi: 10.1038/9304

30.

Chernikov

, Vlassov

, Chernolovskaya

. Current development of siRNA Bioconjugates: From research to the clinic. Front Pharmacol, 2019; 10:444; doi: 10.3389/fphar.2019.00444

31.

Ban

, Ramakrishnan

, Sundaralingam

. A Single 2′-Hydroxyl Group Converts B-DNA to A-DNA: Crystal structure of the DNA-RNA Chimeric Decamer Duplex d(CCGGC)r(G)d(CCGG) with a novel intermolecular G·C Base-paired Quadruplet. J Mol Biol, 1994; 236:275–285; doi: 10.1006/jmbi.1994.1134

32.

Becker

, Ober-Reynolds

, Jouravleva

, et al. High-Throughput analysis reveals rules for target rna binding and cleavage by AGO2. Mol Cell, 2019; 75:741–755.e11; doi: 10.1016/j.molcel.2019.06.012

33.

Schwarz

, Hutvágner

, Du

, et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell, 2003; 115:199–208; doi: 10.1016/S0092-8674(03)00759-1

34.

Yao

, Sasaki Hiroshi

, Ueda

, et al. Single-Molecule analysis of the target cleavage reaction by the drosophila RNAi enzyme complex. Mol Cell, 2015; 59:125–132; doi: 10.1016/j.molcel.2015.05.015

35.

Efthymiou

, Peel

, Huynh

, et al. Evaluation of siRNAs that contain internal variable-length spacer linkages. Bioorg Med Chem Lett, 2012; 22:5590–5594; doi: 10.1016/j.bmcl.2012.07.006

36.

Chou

, Flynn

, Reid

. High-resolution NMR study of a synthetic DNA-RNA hybrid dodecamer containing the consensus Pribnow promoter sequence: D (CGTTATAATGCG).cntdot.r(CGCAUUAUAACG). Biochemistry, 1989; 28:2435–2443; doi: 10.1021/bi00432a014

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.51 MB

0.54 MB

0.53 MB

0.04 MB

Systematic Evaluation of Position-Specific Tolerability of Seven Backbone and Ribose Modifications in Fully Chemically Stabilized siRNAs

Abstract

Get full access to this article

References

Supplementary Material